|
1
|
Eroes CA, Zausinger S, Kreth FW,
Goldbrunner R and Tonn JC: Intramedullary low grade astrocytoma and
ependymoma. Surgical results and predicting factors for clinical
outcome. Acta Neurochir (Wien). 152:611–618. 2010. View Article : Google Scholar
|
|
2
|
Wade A, Hayhurst C, Amato-Watkins A,
Lammie A and Leach P: Cerebellar pilocytic astrocytoma in adults: a
management paradigm for a rare tumour. Acta Neurochir (Wien).
155:1431–1435. 2013. View Article : Google Scholar
|
|
3
|
Schuurman PR, Troost D, Verbeeten B Jr and
Bosch DA: 5-year survival and clinical prognostic factors in
progressive supratentorial diffuse “low-grade” astrocytoma: a
retrospective analysis of 46 cases. Acta Neurochir (Wien). 139:2–7.
1997. View Article : Google Scholar
|
|
4
|
Sturiale CL, Sabatino G, Albanese A, et
al: Subcutaneous malignant melanoma of the scalp surgical flap
after brain irradiation for anaplastic astrocytoma. J Neurooncol.
106:203–207. 2012. View Article : Google Scholar
|
|
5
|
Wick W, Platten M, Meisner C, et al:
Temozolomide chemotherapy alone versus radiotherapy alone for
malignant astrocytoma in the elderly: the NOA-08 randomised, phase
3 trial. Lancet Oncol. 13:707–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsutani T, Nagai Y, Mine S, et al:
Akt/protein kinase B overexpression as an accurate prognostic
marker in adult diffuse astrocytoma. Acta Neurochir (Wien).
151:263–268. 2009.discussion 268. View Article : Google Scholar
|
|
7
|
Imaizumi T, Murakami K, Ohta K, et al:
MDA5 and ISG56 mediate CXCL10 expression induced by toll-like
receptor 4 activation in U373MG human astrocytoma cells. Neurosci
Res. 76:195–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El Hindy N, Bankfalvi A, Herring A, et al:
Correlation of aquaporin-1 water channel protein expression with
tumor angiogenesis in human astrocytoma. Anticancer Res.
33:609–613. 2013.PubMed/NCBI
|
|
9
|
Barton VN, Donson AM, Birks DK, et al:
Insulin-like growth factor 2 mRNA binding protein 3 expression is
an independent prognostic factor in pediatric pilocytic and
pilomyxoid astrocytoma. J Neuropathol Exp Neurol. 72:442–449. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanoke A, Kanamori M, Kumabe T, et al:
Metachronous, multicentric glioma of pilocytic astrocytoma with
oligodendroglioma-like component and oligodendroglioma through
distinct genetic aberrations. J Neurosurg. 118:854–858. 2013.
View Article : Google Scholar
|
|
11
|
Mascelli S, Raso A, Biassoni R, et al:
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene
mutations in pediatric brain tumors: report of a secondary
anaplastic astrocytoma carrying the IDH1 mutation. J Neurooncol.
109:477–484. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Looso M, Michel CS, Konzer A, et al:
Spiked-in pulsed in vivo labeling identifies a new member of the
CCN family in regenerating newt hearts. J Proteome Res.
11:4693–4704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holbourn KP, Acharya KR and Perbal B: The
CCN family of proteins: structure-function relationships. Trends
Biochem Sci. 33:461–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minhas U, Martin TA, Ruge F, Harding KG
and Jiang WG: Pattern of expression of CCN family members Cyr61,
CTGF and NOV in human acute and chronic wounds. Exp Ther Med.
2:641–645. 2011.PubMed/NCBI
|
|
15
|
Jun JI and Lau LF: Taking aim at the
extracellular matrix: CCN proteins as emerging therapeutic targets.
Nat Rev Drug Discov. 10:945–963. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lake AC and Castellot JJ Jr: CCN5
modulates the antiproliferative effect of heparin and regulates
cell motility in vascular smooth muscle cells. Cell Commun Signal.
1:52003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schutze N, Noth U, Schneidereit J,
Hendrich C and Jakob F: Differential expression of CCN-family
members in primary human bone marrow-derived mesenchymal stem cells
during osteogenic, chondrogenic and adipogenic differentiation.
Cell Commun Signal. 3:52005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Banerjee S, Sengupta K, Saxena NK, Dhar K
and Banerjee SK: Epidermal growth factor induces WISP-2/CCN5
expression in estrogen receptor-alpha-positive breast tumor cells
through multiple molecular cross-talks. Mol Cancer Res. 3:151–162.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dhar K, Banerjee S, Dhar G, Sengupta K and
Banerjee SK: Insulin-like growth factor-1 (IGF-1) induces
WISP-2/CCN5 via multiple molecular cross-talks and is essential for
mitogenic switch by IGF-1 axis in estrogen receptor-positive breast
tumor cells. Cancer Res. 67:1520–1526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dhar G, Banerjee S, Dhar K, et al: Gain of
oncogenic function of p53 mutants induces invasive phenotypes in
human breast cancer cells by silencing CCN5/WISP-2. Cancer Res.
68:4580–4587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dhar G, Mehta S, Banerjee S, et al: Loss
of WISP-2/CCN5 signaling in human pancreatic cancer: a potential
mechanism for epithelial-mesenchymal-transition. Cancer Lett.
254:63–70. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ouelaa-Benslama R, De Wever O, Hendrix A,
et al: Identification of a GαGβγ, AKT and PKCα signalome associated
with invasive growth in two genetic models of human breast cancer
cell epithelial-to-mesenchymal transition. Int J Oncol. 41:189–200.
2012.PubMed/NCBI
|
|
23
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Henriksson R, Asklund T and Poulsen HS:
Impact of therapy on quality of life, neurocognitive function and
their correlates in glioblastoma multiforme: a review. J
Neurooncol. 104:639–646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Florian IS, Tomuleasa C, Soritau O, et al:
Cancer stem cells and malignant gliomas. From pathophysiology to
targeted molecular therapy. J BUON. 16:16–23. 2011.PubMed/NCBI
|
|
26
|
Pennica D, Swanson TA, Welsh JW, et al:
WISP genes are members of the connective tissue growth factor
family that are up-regulated in wnt-1-transformed cells and
aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA.
95:14717–14722. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bargonetti J and Manfredi JJ: Multiple
roles of the tumor suppressor p53. Curr Opin Oncol. 14:86–91. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hock AK and Vousden KH: Tumor suppression
by p53: fall of the triumvirate? Cell. 149:1183–1185. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Banerjee S, Dhar G, Haque I, et al:
CCN5/WISP-2 expression in breast adenocarcinoma is associated with
less frequent progression of the disease and suppresses the
invasive phenotypes of tumor cells. Cancer Res. 68:7606–7612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banerjee SK and Banerjee S: CCN5/WISP-2: A
micromanager of breast cancer progression. J Cell Commun Signal.
6:63–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fritah A, Saucier C, De Wever O, et al:
Role of WISP-2/CCN5 in the maintenance of a differentiated and
noninvasive phenotype in human breast cancer cells. Mol Cell Biol.
28:1114–1123. 2008. View Article : Google Scholar :
|
|
32
|
Haque I, Banerjee S, Mehta S, et al:
Cysteine-rich 61-connective tissue growth
factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced
signaling protein-2 (WISP-2) regulates microRNA-10b via
hypoxia-inducible factor-1α-TWIST signaling networks in human
breast cancer cells. J Biol Chem. 286:43475–43485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang CH, Fan TC, Yu JC, et al: The
prognostic significance of RUNX2 and miR-10a/10b and their
inter-relationship in breast cancer. J Transl Med. 12:2572014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haque I, Banerjee S, De A, et al:
CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer
cells through accumulation and trafficking of p27 via Skp2 and
FOXO3a regulation. Oncogene. Aug 18–2014.(Epub ahead of print).
View Article : Google Scholar
|
|
35
|
Han X, Yan S, Weijie Z, et al: Critical
role of miR-10b in transforming growth factor-β1-induced
epithelial-mesenchymal transition in breast cancer. Cancer Gene
Ther. 21:60–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ibrahim SA, Yip GW, Stock C, et al:
Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer
cell motility and invasiveness via a Rho-GTPase- and
E-cadherin-dependent mechanism. Int J Cancer. 131:E884–E896. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferrand N, Stragier E, Redeuilh G and
Sabbah M: Glucocorticoids induce CCN5/WISP-2 expression and
attenuate invasion in oestrogen receptor-negative human breast
cancer cells. Biochem J. 447:71–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma L: Role of miR-10b in breast cancer
metastasis. Breast Cancer Res. 12:2102010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Davies SR, Watkins G, Mansel RE and Jiang
WG: Differential expression and prognostic implications of the CCN
family members WISP-1, WISP-2, and WISP-3 in human breast cancer.
Ann Surg Oncol. 14:1909–1918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Banerjee S, Saxena N, Sengupta K, et al:
WISP-2 gene in human breast cancer: estrogen and progesterone
inducible expression and regulation of tumor cell proliferation.
Neoplasia. 5:63–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Inadera H, Hashimoto S, Dong HY, et al:
WISP-2 as a novel estrogen-responsive gene in human breast cancer
cells. Biochem Biophys Res Commun. 275:108–114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kouzu Y, Uzawa K, Kato M, et al: WISP-2
expression in human salivary gland tumors. Int J Mol Med.
17:567–573. 2006.PubMed/NCBI
|
